Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips UAVS Q3 2023 Earnings EPS Beats Estimate Amid Revenue Absence Stock Surges 505 ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue EEX Q1 2026 Earnings EPS Misses Estimates as Emerald Holding Faces Headwinds Hyperfine Inc HYPR Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps 11 TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment